GET DAILY SIGNALSWhy Is Cerebras Systems (CBRS) Stock Down -7.35% Today?
Key Takeaways
- CBRS shares fell 7.35% to $101.16, down from a prior close of $109.18.
- The primary catalyst was a UBS price-target cut to $250 from $330, the largest analyst revision since the company's May 2026 IPO.
- Residual pressure from a late-October short-seller report on wafer-scale chip durability continued to weigh on sentiment.
- An approaching post-IPO lockup expiration and heavy insider selling added to the supply overhang.
- The decline aligned with broad weakness across AI-computing and cloud-infrastructure names.
- Traders are watching the upcoming November 12 earnings report and the November 9 lockup release.
- For additional detail on valuation, check the Price Targets, Earnings, and Forecast pages.
- Explore automated strategies tracking this and other tickers via Trending AI Robots.
Opening Summary
Cerebras Systems Inc. (CBRS), a Sunnyvale, California-based maker of wafer-scale artificial intelligence chips and cloud AI infrastructure, saw its shares slide 7.35% on Monday, falling to $101.16 from a prior close of $109.18. The stock touched a fresh 52-week low early in the session as markets reacted to a significant analyst price-target reduction, compounded by lingering short-seller concerns and the approaching release of post-IPO lockup shares.
Analyst Price-Target Cut
The sharpest driver of Monday's decline was a UBS revision that lowered its 12-month price target on CBRS to $250 from $330 while maintaining a Buy rating. The magnitude of the cut, the largest analyst adjustment since Cerebras went public in May 2026, signaled reduced conviction in the stock's near-term valuation even among bullish firms. Such downward revisions often trigger selling as investors recalibrate expectations around growth and margin trajectory.
Short-Seller Report Fallout
The selloff extended a slide that began following a report from Culper Research published on October 28. The report alleged that Cerebras' wafer-scale chips degrade after roughly 1.5 to 2.5 years in the field and raised questions about management's statements regarding proprietary connector technology. Cerebras has not issued a formal public response, and the unresolved nature of these claims has kept bearish sentiment in play, contributing to continued downside pressure.
Lockup Expiration and Insider Selling
A large tranche of post-IPO lockup shares is scheduled for release around November 9, roughly a week before the company reports third-quarter earnings. Investors often position defensively ahead of lockup expirations, anticipating a potential increase in the tradable float and selling pressure. This concern is amplified by disclosures that Chief Executive Andrew Feldman and Chief Technology Officer Sean Lie have sold more than $240 million in stock through pre-arranged trading plans since August, adding to the perceived supply overhang.
Sector-Wide Weakness
Monday's move also reflected broader pressure across AI-computing and cloud-infrastructure equities, as several peers including Nebius, CoreWeave, IREN, and Hut 8 traded lower. Market commentary has increasingly focused on the heavy capital spending and debt reliance of hyperscale cloud providers building out AI capacity, prompting investors to reassess valuations across the AI-infrastructure complex. This sector sentiment compounded the stock-specific catalysts facing CBRS.
Market Context and Trading Activity
Trading was notably heavy, with volume running well above the stock's recent daily averages as sellers dominated the session. The decline diverged from a generally firmer open in major equity indices, underscoring that the move was driven by company- and sector-specific factors rather than a broad risk-off environment. Technically, the shares broke below prior support levels and set a new 52-week low, leaving the stock trading well below its $185 IPO price.
What Comes Next for CBRS
Attention now turns to two near-term events for CBRS. The November 9 lockup expiration could bring additional selling, while the company's third-quarter earnings report on November 12 will be scrutinized for hardware revenue growth, cloud-services momentum, and margin trends. Analysts expect elevated volatility around the report, with the market seeking clarity on whether Cerebras can expand hardware sales rather than relying primarily on cloud revenue. Key risks include competitive pressure from Nvidia, unresolved questions from the short-seller report, and ongoing insider selling.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots that have demonstrated the strongest performance under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, with bots varying by strategy, timeframe, performance metrics, and traded symbols. Only the top performers are featured in this section. Explore the page to discover automated strategies that may align with your trading approach.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
CBRS's RSI Indicator is remaining in oversold zone for 1 day
It is expected that a price bounce should occur soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CBRS as a result. In 8 of 8 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CBRS turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 1 similar instances when the indicator turned negative. In 1 of the 1 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CBRS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.501) is normal, around the industry mean (5.894). P/E Ratio (-20.699) is within average values for comparable stocks, (16.337). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry Semiconductors
Advertisement